Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2022 | Highlights in autoimmune diseases from EBMT 2022

Raffaella Greco • 22 Mar 2022
EBMT 2022
General

Raffaella Greco, MD, PhD, San Raffaele Hospital, Milan, Italy, shares her highlights from this year’s EBMT 2022. Dr Greco first talks on Prof. Richard Burt’s achievements and impact in the field of transplantation in autoimmune disorders, also mentioning Helen’s Jessop’s valuable contribution to the Autoimmune Diseases Working Party (ADWP). She also emphasizes the importance of working together with all healthcare stakeholders. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.

More from Raffaella Greco

Where is the field of CAR-T moving for the treatment of autoimmune diseases?
1:28
Where is the field of CAR-T moving for the treatment of autoimmune diseases?
Raffaella Greco • 5 Feb 2026
An update on the rapidly evolving field of CAR T-cell therapy in autoimmune diseases
4:26
An update on the rapidly evolving field of CAR T-cell therapy in autoimmune diseases
Raffaella Greco • 5 Feb 2026
Improving patient selection and referral for CAR T-cell therapy in autoimmune diseases
2:08
Improving patient selection and referral for CAR T-cell therapy in autoimmune diseases
Raffaella Greco • 5 Feb 2026
The rapidly evolving role of transplantation and CAR-T in autoimmune disease
1:21
The rapidly evolving role of transplantation and CAR-T in autoimmune disease
Raffaella Greco • 31 Mar 2025

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals